发明名称 Bridged heterocyclic compounds and methods of use
摘要 This disclosure relates to new compounds that may be used to modulate a histamine receptor in an individual. Novel compounds are described, including new bridged heterocyclic [4,3-b]indole compounds. Pharmaceutical compositions are also provided. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
申请公布号 US9051314(B2) 申请公布日期 2015.06.09
申请号 US201314033234 申请日期 2013.09.20
申请人 Medivation Technologies, Inc. 发明人 Hung David T.;Protter Andrew Asher;Chakravarty Sarvajit;Jain Rajendra Parasmal
分类号 A61K31/54;C07D451/00;C07D471/18;C07D471/08 主分类号 A61K31/54
代理机构 Morrison & Foerster LLP 代理人 Morrison & Foerster LLP
主权项 1. A method of treating a disorder in an individual in need thereof, wherein the disorder is schizophrenia, comprising administering to the individual an effective amount of a compound of the formula (A-2):wherein: R1 is unsubstituted C1-C8 alkyl; each X7, X8, X9 and X10 is independently N or CR4; q is 0; each R4 is independently H, hydroxyl, nitro, cyano, halo, C1-C8 perhaloalkyl, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C2-C8 alkenyl, substituted or unsubstituted C2-C8 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, C1-C8 perhaloalkoxy, C1-C8 alkoxy, aryloxy, carboxyl, thiol, carbonylalkoxy, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aralkyl, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl, carbonylalkylenealkoxy, alkylsulfonylamino or acyl; each R8c, R8d and R8f is independently H, hydroxyl, C1-C8 alkyl, C1-C8 perhaloalkyl, carboxy or carbonylalkoxy; R8e is independently hydroxyl, C1-C8 alkyl, C1-C8 perhaloalkyl, carboxy or carbonylalkoxy; and Q is a substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted C3-C8 cycloalkyl, substituted or unsubstituted C3-C8 cycloalkenyl, substituted or unsubstituted heterocyclyl, unsubstituted amino, substituted amino, alkoxy, aminoacyl, acyloxy, carbonylalkoxy, aminocarbonylalkoxy or acylamino; or a pharmaceutically acceptable salt thereof.
地址 San Francisco CA US